These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21712293)

  • 1. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II.
    Cleland JG; Coletta AP; Freemantle N; Clark AL
    Eur J Heart Fail; 2011 Jul; 13(7):805-8. PubMed ID: 21712293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.
    Cleland JG; Coletta AP; Buga L; Ahmed D; Clark AL
    Eur J Heart Fail; 2010 Jun; 12(6):623-9. PubMed ID: 20498271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.
    Cleland JG; Coletta AP; Clark AL
    Eur J Heart Fail; 2007; 9(6-7):740-5. PubMed ID: 17481946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.
    Cleland JG; Coletta AP; Clark AL; Cullington D
    Eur J Heart Fail; 2009 Jun; 11(6):622-30. PubMed ID: 19468023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.
    Coletta AP; Cullington D; Clark AL; Cleland JG
    Eur J Heart Fail; 2008 Dec; 10(12):1264-7. PubMed ID: 19008149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF.
    Cleland JG; Coletta AP; Castiello T; Clark AL
    Eur J Heart Fail; 2011 Oct; 13(10):1147-51. PubMed ID: 21896537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
    Cleland JG; Freemantle N; Coletta AP; Clark AL
    Eur J Heart Fail; 2006 Jan; 8(1):105-10. PubMed ID: 16387630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update.
    Cleland JG; Coletta AP; Cullington D; Castiello T; de Boer RA; Clark AL
    Eur J Heart Fail; 2011 Dec; 13(12):1376-80. PubMed ID: 22102626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.
    Cleland JG; Coletta AP; Torabi A; Clark AL
    Eur J Heart Fail; 2009 Aug; 11(8):802-5. PubMed ID: 19633104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.
    Cleland JG; Coletta AP; Abdellah AT; Nasir M; Hobson N; Freemantle N; Clark AL
    Eur J Heart Fail; 2007 Jan; 9(1):92-7. PubMed ID: 17188569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
    Coletta AP; Tin L; Loh PH; Clark AL; Cleland JG
    Eur J Heart Fail; 2006 Aug; 8(5):547-9. PubMed ID: 16887387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.
    Cleland JG; Coletta AP; Buga L; Antony R; Pellicori P; Freemantle N; Clark AL
    Eur J Heart Fail; 2011 Apr; 13(4):460-5. PubMed ID: 21436363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.
    Cleland JG; Coletta AP; Abdellah AT; Cullington D; Clark AL; Rigby AS
    Eur J Heart Fail; 2008 Jan; 10(1):102-8. PubMed ID: 18179987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M
    Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial.
    Acker MA; Jessup M; Bolling SF; Oh J; Starling RC; Mann DL; Sabbah HN; Shemin R; Kirklin J; Kubo SH
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):569-74, 574.e1. PubMed ID: 21269649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study].
    García-Pinilla JM; Jiménez-Navarro MF; Anguita-Sánchez M; Martínez-Martínez A; Torres-Calvo F;
    Rev Esp Cardiol; 2007 Jan; 60(1):38-44. PubMed ID: 17288954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.